Constitutive gp130-JAK-STAT3 signaling induces a plasma cell malignancy featuring all characteristics of human myeloma - a novel in vivo myeloma model for a patient subgroup with STAT3 activation

被引：0
|
作者：
Steidle, S. [1 ]
Dechow, T. [1 ]
Goetze, K. [1 ]
Rudelius, M. [2 ]
Kratzat, S. [1 ]
Behnke, K. [1 ]
Pechloff, K. [3 ]
Bullinger, L. [4 ]
Fend, F. [5 ]
Mitova, N. [1 ]
Li, Z. [6 ]
Thaler, M. [3 ]
Bauer, J. [7 ]
Pietschmann, E. [1 ]
Albers, C. [1 ]
Grundler, R. [1 ]
Ruland, J. [3 ]
Peschel, C. [1 ]
Duyster, J. [8 ]
Rose-John, S. [9 ]
Bassermann, F. [1 ]
Keller, U. [1 ]
机构：
[1] Tech Univ Munich, Dept Med 3, D-80290 Munich, Germany
[2] Univ Wurzburg, Inst Pathol, Wurzburg, Germany
[3] Tech Univ Munich, Inst Clin Chem & Pathobiochem, D-80290 Munich, Germany
[4] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany
[5] Univ Tubingen, Inst Pathol, Tubingen, Germany
[6] Tech Univ Munich, Dept Nucl Med, D-80290 Munich, Germany
[7] Tech Univ Munich, Inst Radiol, D-80290 Munich, Germany
[8] Univ Freiburg, Dept Med 1, D-79106 Freiburg, Germany
[9] Univ Kiel, Inst Biochem, Kiel, Germany
来源：
ONCOLOGY RESEARCH AND TREATMENT | 2014年 / 37卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
V592
引用
收藏
页码：192 / 192
页数：1
相关论文
共 50 条
  • [1] Constitutive gp130-JAK-STAT3 Signaling Induces a Plasma Cell Disorder Representing Genetic and Clinical Features of Human Myeloma - a Novel in Vivo Model for the Patient Subgroup Characterized By a STAT3 Target Gene Signature
    Steidle, Sabine
    Dechow, Tobias
    Goetze, Katharina
    Rudelius, Martina
    Pechloff, Konstanze
    Behnke, Kerstin
    Bullinger, Lars
    Fend, Falko
    Valeria, Soberon
    Schmidt-Supprian, Marc
    Bassermann, Florian
    Ruland, Juergen
    Peschel, Christian
    Keller, Ulrich
    BLOOD, 2014, 124 (21)
  • [2] Conditional gp130-JAK-STAT3 activation induces malignant transformation in vivo
    Scherger, A. K.
    Schick, M.
    Steiger, K.
    Al-Maarri, M.
    Wunderlich, F. T.
    Rose-John, S.
    Peschel, C.
    Keller, U.
    ONCOLOGY RESEARCH AND TREATMENT, 2017, 40 : 82 - 82
  • [3] Inhibition of gp130 signaling in breast cancer blocks constitutive activation of Stat3 and inhibits in vivo malignancy
    Selander, KS
    Li, L
    Watson, L
    Merrell, M
    Dahmen, H
    Heinrich, PC
    Müller-Newen, G
    Harris, KW
    CANCER RESEARCH, 2004, 64 (19) : 6924 - 6933
  • [4] Constitutive activation of Stat3 signaling confers resistance to apoptosis in human U266 myeloma cells
    Catlett-Falcone, R
    Landowski, TH
    Oshiro, MM
    Turkson, J
    Levitzki, A
    Savino, R
    Ciliberto, G
    Moscinski, L
    Fernández-Luna, JL
    Nuñez, G
    Dalton, WS
    Jove, R
    IMMUNITY, 1999, 10 (01) : 105 - 115
  • [5] Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines - Inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells
    Lin, Q
    Lai, R
    Chirieac, LR
    Li, CP
    Thomazy, VA
    Grammatikakis, L
    Rassidakis, GZ
    Zhang, W
    Fujio, Y
    Kunisada, K
    Hamilton, SR
    Amin, HM
    AMERICAN JOURNAL OF PATHOLOGY, 2005, 167 (04): : 969 - 980
  • [6] Constitutive activation of Stat3 in human prostate tumors and cell lines: Direct inhibition of Stat3 signaling induces apoptosis of prostate cancer cells
    Mora, LB
    Buettner, R
    Seigne, J
    Diaz, J
    Ahmad, N
    Garcia, R
    Bowman, T
    Falcone, R
    Fairclough, R
    Cantor, A
    Muro-Cacho, C
    Livingston, S
    Karras, J
    Pow-Sang, J
    Jove, R
    CANCER RESEARCH, 2002, 62 (22) : 6659 - 6666
  • [7] Constitutive activation of Stat3 signaling abrogates apoptosis in squamous cell carcinogenesis in vivo
    Grandis, JR
    Drenning, SD
    Zeng, Q
    Watkins, SC
    Melhem, MF
    Endo, S
    Johnson, DE
    Huang, L
    He, YK
    Kim, JD
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (08) : 4227 - 4232
  • [8] Novel JAK2 inhibitor blocks STAT3 and MAPK signaling pathways, inhibits proliferation and induces apoptosis of human myeloma cells
    Scuto, Anna
    Wu, Jun
    Wang, Yan
    Kretzner, Leo
    Yen, Yun
    Zinda, Michael
    Huszar, Dennis
    Jove, Richard
    CANCER RESEARCH, 2009, 69
  • [9] Sanguinarine Induces Apoptosis Pathway in Multiple Myeloma Cell Lines via Inhibition of the JaK2/STAT3 Signaling
    Akhtar, Sabah
    Achkar, Iman W.
    Siveen, Kodappully S.
    Kuttikrishnan, Shilpa
    Prabhu, Kirti S.
    Khan, Abdul Q.
    Ahmed, Eiman, I
    Sahir, Fairooz
    Jerobin, Jayakumar
    Raza, Afsheen
    Merhi, Maysaloun
    Elsabah, Hesham M.
    Taha, Ruba
    El Omri, Halima
    Zayed, Hatem
    Dermime, Said
    Steinhoff, Martin
    Uddin, Shahab
    FRONTIERS IN ONCOLOGY, 2019, 9
  • [10] The novel JAK inhibitor AZD1480 blocks STAT3 and FGFR3 signaling, resulting in suppression of human myeloma cell growth and survival
    Scuto, A.
    Krejci, P.
    Popplewell, L.
    Wu, J.
    Wang, Y.
    Kujawski, M.
    Kowolik, C.
    Xin, H.
    Chen, L.
    Wang, Y.
    Kretzner, L.
    Yu, H.
    Wilcox, W. R.
    Yen, Y.
    Forman, S.
    Jove, R.
    LEUKEMIA, 2011, 25 (03) : 538 - 550
12345